Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

19 results about "Immune mechanisms" patented technology

The immune mechanism is designed to protect the body against attack from invading microorganisms and foreign, potentially harmful molecules. There are four types of immune mechanisms. The nature of the invading antigen determines which type of mechanism is brought into action.

Distributed energy agent regulation and control method and system based on deep reinforcement learning

The invention discloses a distributed energy agent regulation and control method and system based on deep reinforcement learning, and the method comprises the following steps: collecting distributed energy operation data and network constraint data in a micro-grid or park power distribution network, and carrying out the preprocessing; constructing a reinforcement learning environment state representation vector; configuring a distributed energy agent set; obtaining a disturbance antigen fingerprint entry set, and generating an immunoaffinity score sequence; generating a normal regulation and control action instruction set, combining and issuing to execute or enter a perturbation sampling process; generating a feasible action domain and a perturbation action candidate set, and executing exploration control contract verification; a target perturbation action is selected and issued for execution or a corrected perturbation action is generated and issued for execution; and updating the deep reinforcement learning strategy network. According to the method, deep reinforcement learning and disturbance immune mechanisms are adopted, distributed energy intelligent agent cooperative regulation and control are achieved, and the method has the advantages of being high in safety, high in adaptability and good in stability.
Owner:北京集联软件科技有限公司

Method for detecting cynomolgus monkey peripheral blood T lymphocyte subtype pSTAT4 and Ki67 signals by flow cytometry

The invention provides a method for detecting subtype pSTAT4 and Ki67 signals of peripheral blood T lymphocytes of machin through flow cytometry, and belongs to the technical field of biological detection. According to the method, the integrated analysis of the multi-dimensional functional state of the cynomolgus monkey T lymphocyte is realized, key signal channel activation and proliferation information of different subgroup cells can be synchronously obtained through a single experiment, and the detection comprehensiveness and efficiency are greatly improved. According to the method, an accurate tool capable of directly evaluating the response intensity and proliferation potential of T cells is provided for immune mechanism research based on a machin model, particularly immune therapy or disease research related to regulation and control of pathways such as IL-12 / STAT4 and the like, and the data dimension and reliability of preclinical immunological evaluation are remarkably enhanced.
Owner:WESTCHINA-FRONTIER PHARMATECH CO LTD

Application of gene mos4 and its encoded protein in regulating plant resistance to phytopathogenic pythium

The application belongs to the technical field of bio-agriculture, and particularly relates to a gene MOS4 and application of an encoded protein thereof in regulation of plant resistance to parasitic Phytophthora. MOS4 Through gene function research, it is found that overexpression of the gene MOS4 significantly improves the plant resistance to parasitic Phytophthora, and that the expression of the gene MOS4 weakens the plant resistance to parasitic Phytophthora, and that the gene MOS4 positively regulates the plant resistance to parasitic Phytophthora. Further immune mechanism research finds that the gene MOS4 regulates the related genes of a salicylic acid (SA) signal path, interacts with a transcription factor ERF019, and jointly activates the plant immune response. In addition, a dual luciferase experiment proves that the gene MOS4 and the gene ERF019 cooperatively regulate the transcription of PR1. The application provides a new molecular target for prevention and treatment of plant diseases caused by parasitic Phytophthora, and has important agricultural application value.
Owner:SHENZHEN RESEARCH INSTITUTE OF NORTHWEST A & F UNIVERSITY

Use of the gene disc1 and its encoded protein in modulating plant resistance to the parasitic phytopathogen phytophthora

This invention belongs to the field of bio-agricultural technology, specifically relating to genes. DISC1 The application of its encoded proteins in regulating plant resistance to Phytophthora parasiticans. This invention, through the study of... DISC1 Studies on the function of genes and their encoded proteins have revealed that... DISC1 Negative regulation of plant resistance to Phytophthora parasiticum. Overexpressed genes. DISC1 Significantly reduces plant resistance to Phytophthora parasiticum, gene DISC1 The mutant plants exhibited significantly enhanced resistance to Phytophthora parasiticum. Further research into the immune mechanism revealed that the gene... DISC1 This invention regulates plant immune responses by modulating genes related to the jasmonic acid (JA) signaling pathway. It provides a novel gene resource for the control of plant resistance to Phytophthora parasiticum.
Owner:SHENZHEN RESEARCH INSTITUTE OF NORTHWEST A & F UNIVERSITY

The application discloses an sgRNA group targeting a DYA gene, a primer pair amplifying a target sequence, a plasmid group and application thereof.

ActiveCN116024216BFermentationVector-based foreign material introductionFrameshift mutationProtein structure and function
The present application relates to the field of genetic engineering, in particular to a sgRNA group targeting DYA gene, a primer pair for amplifying target sequence, a plasmid group and application thereof. The sgRNA group designed by the present application edits the sheep DYA gene, and after gene editing, large fragment deletion occurs and causes frame shift mutation, which causes great damage to the protein structure and function encoded by the DYA gene. The experimental results show that different fragment lengths of gene editing can be caused in the target region, the overall editing efficiency of the first exon reaches 76.4%, and the overall editing efficiency of the second exon reaches 84.09%. Editing occurs on both sets of chromosomes in the genome (i.e. homozygote): the homozygote editing efficiency of the first exon is 30.9%, and the homozygote editing efficiency of the second exon is 9.1%. The sgRNA group provided by the present application has important significance in the study of ruminant evolution and related immune mechanisms.
Owner:JIANGSU QIANBAO ANIMAL HUSBANDRY CO LTD

A method for constructing a scleroderma model of pbmc humanized mice

This invention discloses a method for constructing a PBMC-derived humanized mouse scleroderma model. Human peripheral blood mononuclear cells are transplanted into immunodeficient mice, and a human immune system is reconstructed in the mice. Bleomycin is injected into the local skin of the mice in a round-point manner to induce fibrosis and form a scleroderma model. This application can more comprehensively simulate the complex pathological process of immune abnormalities and tissue fibrosis coexisting in human scleroderma, and provides a more realistic and systematic experimental platform for in-depth exploration of the immune mechanism of this disease.
Owner:SHANGHAI SIXIN PHARM TECH CO LTD

A data storage and visualization processing system

PendingCN122389103AData displayAntigen
The application belongs to the technical field of data processing, and particularly relates to a data storage and visual processing system. The system comprises: a heterogeneous data acquisition component for multi-source data preprocessing and feature extraction; a secure distributed storage component for maintaining data integrity and synchronously resisting antigen information by using a hash linked list and a redundancy mechanism; an immune clone detection and analysis device for simulating an immune mechanism to recognize abnormalities through affinity matching and perform clone variation to accurately lock tampering areas; an adversarial generation evolution device for constructing a game defense mechanism to improve the detection accuracy and early warning capability for unknown attacks; and a dynamic defense visual rendering engine for assigning different visual coding parameters to different security level data areas according to the detection results. The application realizes the transformation from passive data display to active defense display by deeply coupling the immune adaptive mechanism and the adversarial generation network, and enhances the detection efficiency and visual feedback capability of the system for complex and dynamic variation attacks.
Owner:ZHENGZHOU SODA INTELLIGENT TECH CO LTD

Method for constructing gcrv-susceptible gobiocypris rarus strain based on isg58 knockout and application thereof

PendingCN122235234AHydrolasesMicroinjection basedIndicator organismMutant
This invention relates to the field of biotechnology, specifically disclosing a method for constructing and applying a rare gudgeon strain susceptible to GCRV based on ISG58 knockout. The key technical points are as follows: This invention employs CRISPR / Cas9 gene editing technology to design dual-target sgRNAs targeting the ISG58 gene of rare gudgeon (target 1 induces a -2 bp deletion, and target 2 mediates an -8 bp deletion). The sgRNA sequence is optimized using ZiFiT target design software, and target specificity is ensured by NCBI BLAST alignment. The in vitro transcribed sgRNA and Cas9 protein are co-microinjected into rare gudgeon fertilized eggs to obtain F0 generation chimeras; after self-crossing of F1 generation heterozygotes, homozygous mutants conforming to Mendelian inheritance laws are successfully screened in the F2 generation. This invention, based on ISG58 knockout, obtains a rare gudgeon strain more sensitive to GCRV infection, which not only provides an important model for subsequent research on antiviral immune mechanisms in fish but also serves as an indicator organism for GCRV in aquaculture environments.
Owner:HUNAN AGRI UNIV

Base editing and monitoring system for gene linkage imbalance

The invention discloses a basic group editing and monitoring system for gene linkage imbalance. The basic group editing and monitoring system comprises guide RNA (Ribonucleic Acid) designed for molecular targets obtained by screening transcription factor mediated gene linkage imbalance, a magnetic navigation-lipidosome nano-particle carrier and a reagent used by a space group imaging technology. According to the invention, magnetic navigation is combined with ferric oxide magnetic nanoparticles-lipid nanoparticles, so that the beneficial effects of improving editing targeting and efficiency and achieving accurate delivery are achieved; according to the method, multiple sites of the gene are edited at the same time, and overall intervention is carried out on the multiple sites of the gene linkage imbalance; the imaging system introduced by the invention can realize monitoring and spatial characterization of linkage imbalance, and is helpful for analyzing an immune mechanism.
Owner:BEIHANG UNIV

Application of gene MOS4 and encoded protein thereof in regulation and control of phytophthora parasitica resistance of plants

The invention belongs to the technical field of biological agriculture, and particularly relates to application of a gene MOS4 and an encoding protein thereof to regulation and control of phytophthora parasitica resistance of plants. The gene function research on the gene MOS4 shows that the resistance of plants to phytophthora parasitica is remarkably improved by overexpressing the gene MOS4, the weakening of the phytophthora parasitica resistance of expression plants of the gene MOS4 is reduced, and the gene MOS4 is found to positively regulate the phytophthora parasitica resistance of the plants. The further study on the immune mechanism finds that the gene MOS4 regulates a salicylic acid (SA) signal channel related gene and interacts with a transcription factor ERF019 to jointly activate the plant immune response. In addition, a dual luciferase experiment proves that MOS4 and ERF019 cooperatively regulate and control transcription of PR1. The invention provides a new molecular target for preventing and treating plant parasitic phytophthora diseases, and has important agricultural application value.
Owner:SHENZHEN RESEARCH INSTITUTE OF NORTHWEST A & F UNIVERSITY

Application of gene DISC1 and encoding protein thereof in regulation and control of phytophthora parasitica resistance of plants

The invention belongs to the technical field of biological agriculture, and particularly relates to application of a gene DISC1 and an encoding protein thereof to regulation and control of phytophthora parasitica resistance of plants. The functional research on the DISC1 and the encoded protein thereof finds that the gene DISC1 negatively regulates the resistance of plants to parasitic phytophthora. The over-expressed gene DISC1 significantly reduces the resistance of the plant to phytophthora parasitica, and the phytophthora parasitica resistance of the gene DISC1 mutant plant is significantly enhanced. The further study on the immune mechanism finds that the gene DISC1 regulates and controls the plant immune response by regulating and controlling the jasmonic acid (JA) signal channel related genes. The invention provides a new gene resource for preventing and treating parasitic phytophthora diseases of plants.
Owner:SHENZHEN RESEARCH INSTITUTE OF NORTHWEST A & F UNIVERSITY

High-dimensional user portrait construction method based on multi-source data fusion and dynamic update

PendingCN122241426AApoptosisEngineering
This invention relates to the fields of artificial intelligence and big data processing, specifically disclosing a method for constructing high-dimensional user profiles based on multi-source data fusion and dynamic updates. This method constructs an initial high-dimensional feature vector, introduces an immune mechanism to identify "self" and "non-self" behaviors, establishes a dynamic antibody library with a lifecycle, and combines clonal selection, high-frequency mutation, and natural apoptosis mechanisms to achieve adaptive evolution of the profile. It also constructs a cross-user immune network, utilizes common group behaviors to generate regulatory factors to correct individual biases, and integrates adversarial attack detection, version management, and viability assessment modules. Through the above technical solutions, this invention improves the accuracy, timeliness, and anti-interference capability of user profiles, providing highly reliable data support for precision marketing, intelligent recommendation, and risk prevention and control.
Owner:SHENZHEN POLY NETWORK TECH CO LTD

Recombinant genes for increasing protein expression level and expression duration of co-transfected mRNAs and applications thereof

The application discloses a kind of recombinant genes for increasing the protein expression level and expression length of co-transfected mRNA, and belongs to mRNA genetic engineering technology;The polypeptide encoded by the recombinant gene is a polypeptide with ribonuclease III activity, which is not inhibited by ribonuclease inhibitor and does not degrade single-stranded RNA;The recombinant gene and the target gene can be constructed in series or in parallel to form a fusion protein or an independently expressed recombinant protein;Or isolated by 2A peptide, internal ribosome entry site, etc., to express independent recombinant enhancement protein and target protein;The recombinant enhancement protein inhibits the innate immune mechanism and mRNA degradation mechanism of the host cell by degrading dsRNA, tRNA, miRNA and its precursor molecules, so that the protein expression level of co-transfected gene is increased by 3-4 times, and the expression time is prolonged by nearly 1 time;In addition, the present application inhibits the innate immune response to degrade impurities by rR3GE, and promotes the storage time of LNP preparation.
Owner:CHENGDU NUOEN BIOLOG TECHNOLOGY CO LTD

A streptococcus suis type 2 polyepitope inhaled subunit vaccine and use thereof

ActiveCN121021709BBacterial antigen ingredientsAntibacterial agentsRibosomal protein E-L30Ctl epitope
The application belongs to the technical field of biotechnology, and provides a Streptococcus suis type 2 (SS2) multi-epitope inhalation subunit vaccine and application thereof.Four CTL epitopes, seven HTL epitopes and six B cell epitopes are screened from the conserved epitopes of SS2 virulence factors SSU05-1022 and SpaA, and the four CTL epitopes, the seven HTL epitopes and the six B cell epitopes are fused by AAY / GPGPG / EAAAK linkers and introduced into L7 / L12 ribosomal protein as an adjuvant to construct an inhalation subunit vaccine 1022-SpaA V3.The vaccine is intranasally primed and boosted at 60 μg, can improve respiratory mucosa sIgA and serum IgG levels, activate related immune cells, and form a mucosal and systemic double immune mechanism.The survival rate of mice after SS2 multi-strain challenge is up to 100%, and the bacterial load can be reduced.The vaccine is safe and non-toxic, inhalation can save cost, and is suitable for industrial scale production.
Owner:JILIN UNIVERSITY

Antiviral properties of eugenia aromaticum, cymbopogon martinii, melaleuca viridiflora, and calophyllum inophyllum essential oils: modulation of e7 and e2 protein pathways in human papillomavirus (HPV) infection

PCT designated stageWO2026035211A1Antibacterial agentsAntimycoticsHuman papillomavirusEugenol
The invention is a composition for the treatment of HPV infections, which, with its components containing [3-caryophyllene, geranyl acetate, geraniol, and nerol, modulates the E7 and E2 protein pathways to provide a natural supportive therapeutic effect in managing HPV infections, exhibits antiviral, antibacterial, and immunomodulatory activity, significantly reduces viral replication, and suppresses protein expression, Contains Eugenia aromaticum (clove oil), which prevents viral replication by disrupting the structural integrity of cell membranes, exhibiting antimicrobial and antiviral activity with its high eugenol content, and Contains Cymbopogon martinii (palmarosa oil), which disrupts viral cell walls and inhibits the replication process, exhibiting antiviral and antibacterial properties with its high geraniol and citronellal content, and Contains Melaleuca viridiflora (niaouli oil), which strengthens cellular immune mechanisms to limit the intracellular spread of viruses and exhibits antiviral and immunomodulatory effects with its viridiflorol content.
Owner:ART DE HUILE AROMA TERAPI HIZMETLERI SANAYI & TICARET ANONIM SIRKETI

Power line communication self-healing method and system based on immune mechanism

The invention provides a power line communication self-healing method and system based on an immune mechanism, and the method comprises the steps: obtaining power line communication data, constructing a digital communication cell based on the power line communication data, obtaining the cell state data of the digital communication cell after communication transmission, the method comprises the following steps: constructing and training a communication immune model comprising a channel detection sub-module and a decoupling analysis sub-module, performing damage detection and root cause analysis on cell state data based on the communication immune model, generating a damage root cause analysis result, performing damage positioning according to the damage root cause analysis result, and performing damage healing based on a hierarchical collaborative self-healing mechanism. Therefore, the accurate positioning of the anomaly source and the rapid repair of the communication anomaly are realized.
Owner:SOUTHERN POWER GRID DIGITAL GRID RESEARCH INSTITUTE CO LTD

Nb nlr39-2 gene and application thereof

PendingCN122146717ABacteriaMicrobiological testing/measurementBiotechnologyAnti viral immunity
This invention belongs to the field of plant biotechnology, and in particular, it relates to... NbNLR39-2 Gene and its application. This invention demonstrates, through stable transformation tests and resistance phenotype observations, that NbNLR39-2 positively regulates the resistance of Nicotiana benthamiana to TuMV. Overexpression of NbNLR39-2 significantly inhibits TuMV replication and accumulation, confers resistance to TuMV in Nicotiana benthamiana; while knockout of this gene leads to increased sensitivity to TuMV in plants. This invention discovers… NbNLR39-2 Genes can be used to prepare transgenic plants, as molecular markers for plant breeding, and to elucidate NLR-mediated antiviral immune mechanisms, among other applications.
Owner:NINGBO UNIV

Flow cytometry method for intracellular factors of immune cells of intestinal tissues of mice

The invention discloses a flow cytometry method for an intracellular factor of an immune cell of a mouse intestinal tissue, which comprises the following steps: inducing expression of the intracellular factor of the mouse by using an in-vivo activating reagent, carrying out warm dissociation on the mouse intestinal tissue, and carrying out a stepped staining process of Fc receptor closing, dead and living staining, surface marker staining, fixed membrane rupture and intracellular factor staining. And synchronous analysis of immune cell subpopulation typing and functional factor expression can be realized without traditional in-vitro cell culture and intracellular factor secretion blocking. The detection result has high sensitivity and accuracy, through DNA enzyme digestion and a standardized dyeing process, the recovery rate of live immune cells is increased by 40% or above, the signal-to-noise ratio of intracellular factor detection is remarkably increased, the result accuracy is better than that of a traditional method, and the method is wide in application, is suitable for immune mechanism research of models of intestinal inflammation, autoimmune diseases, infectious diseases and the like, and has wide application prospects. And activity screening and efficacy evaluation of the immunomodulatory drug are carried out.
Owner:WUXI XISHAN NJU INSTITUTE OF APPLIED BIOTECHNOLOGY